Oxidative stress and inflammation are responsible for the damage to the RPE (retinal pigment epithelium) and choriocapillary associated with Age-related Macular Degeneration (AMD). When significant, such damages can cause AMD to develop into exudative macular degeneration (wet AMD). . Inflammation causes other ophthalmic alterations, such as the occurrence of Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME).
The specific characteristics of the active ingredients of Retimix aid conventional drug therapies in the treatment of eye degenerative diseases associated with multifactorial pathogenesis that is dependent on the combination of inflammatory and angiogenesis processes.
Casperiva® is an Eye Pharma SpA brand
Phytosome® is an Indena SpA brand